Literature DB >> 10706985

The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia.

S R McGurk1, P J Moriarty, P D Harvey, M Parrella, L White, K L Davis.   

Abstract

Cognitive dysfunction is increasingly being recognized as a major contributor to the adaptive impairment seen in most patients with schizophrenia. Reported here is a prospective longitudinal evaluation of the relationship between cognitive and adaptive functioning in elderly patients with schizophrenia. It was hypothesized that baseline cognitive and negative, but not positive symptoms, would be predictive of cross-sectional impairment and longitudinal outcome. Subjects were 168 elderly patients with schizophrenia, free of major neurological disorders, who were residents of a long-term psychiatric facility. Subjects were assessed at baseline and again an average of 15months later. The PANSS was used to assess the severity of symptoms of schizophrenia. Cognitive symptoms were assessed using the components of the CERAD cognitive battery. Social and adaptive functioning was assessed using the SAFE scale. Spearman correlations were determined among clinical variables, and the rank ordering of prediction of SAFE scale scores at follow-up was determined using a stepwise regression procedure. At follow-up, adaptive life skills correlated with cognitive performance and negative symptoms (Spearman rho values 0. 41-0.57, all p values <0.0001), but not positive symptoms (r=0.09, n. s.). Among cognitive tasks, verbal learning and memory were most highly correlated with adaptive skills at follow-up. These results confirm and extend previous studies that indicate that cognitive impairments are predictive, both cross-sectionally and longitudinally, of adaptive life skills in persons with schizophrenia. Negative symptoms, but not positive symptoms, were correlated with impaired adaptive skills. Taken together, these results underscore the need to develop more effective treatments for cognitive and negative symptoms in schizophrenia.

Entities:  

Mesh:

Year:  2000        PMID: 10706985     DOI: 10.1016/s0920-9964(99)00097-3

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  22 in total

1.  The stress process perspective and adaptation of people with schizophrenia--an exploratory study.

Authors:  Yves Lecomte; Céline Mercier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-02       Impact factor: 4.328

2.  Outcome revealed by preference in schizophrenia (OPS): development of a new class of outcome measurements.

Authors:  Bruno Falissard; Nadine Bazin; Marie-Christine Hardy-Bayle
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

3.  Factor structure of the BPRS in deaf people with schizophrenia: correlates to language and thought.

Authors:  Heather K Horton; Steven M Silverstein
Journal:  Cogn Neuropsychiatry       Date:  2011-04-08       Impact factor: 1.871

Review 4.  Is there evidence for late cognitive decline in chronic schizophrenia?

Authors:  Jharna N Shah; Salah U Qureshi; Ali Jawaid; Paul E Schulz
Journal:  Psychiatr Q       Date:  2012-06

Review 5.  Management of negative symptoms of schizophrenia.

Authors:  D C Javitt
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 6.  Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment.

Authors:  Louis S Matza; Robert Buchanan; Scot Purdon; Jessica Brewster-Jordan; Yang Zhao; Dennis A Revicki
Journal:  Schizophr Bull       Date:  2006-07-07       Impact factor: 9.306

7.  Right-hemisphere encephalopathy in elderly subjects with schizophrenia: evidence from neuropsychological and brain imaging studies.

Authors:  V S Gabrovska-Johnson; M Scott; S Jeffries; N Thacker; R C Baldwin; A Burns; S W Lewis; J F W Deakin
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

8.  Do antipsychotics limit disability in schizophrenia? A naturalistic comparative study in the community.

Authors:  Jagadisha Thirthalli; Basappa K Venkatesh; Magadi N Naveen; Ganesan Venkatasubramanian; Udupi Arunachala; Kengeri V Kishore Kumar; Bangalore N Gangadhar
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

9.  Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life.

Authors:  Christina Ting; Tarek K Rajji; Zahinoor Ismail; David F Tang-Wai; Nina Apanasiewicz; Dielle Miranda; David Mamo; Benoit H Mulsant
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

10.  Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-22       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.